Fischer Medical Ventures Board Meeting on Aug 14 to Approve Unaudited Results

Fischer Medical Ventures Ltd has announced that its Board of Directors will convene on August 14, 2026, via video conference. The primary agenda items include the consideration and approval of the unaudited standalone and consolidated financial results for the quarter ending June 30, 2026. Additionally, the board will address any other matters specified in the agenda. The trading window for company shares remains closed for designated persons until 48 hours after the declaration of these financial results.